Clarus Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Clarus Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	148	171	212	229	224	266	315	286	264	250
Cost of revenue	105	117	138	149	146	178	205	189	172	167
Gross profit	43.7	53.8	74	80.3	77.8	87.9	110	97.5	92.6	83
Research and development	6.6	7.98	9.47	10.6	10.2	10.4	13	12.7	12.2	11.9
Selling, general and administrative	49.9	56.3	65.2	68.7	71.4	90.7	121	115	112	105
Operating expenses	49.7	58.6	65.8	68.9	73.9	101	216	119	163	143
Operating income	-5.97	-4.82	8.17	11.4	3.93	-12.7	-106	-21.1	-70.4	-59.7
Other non-operating income	-2.34	-0.95	-1.7	-1.45	-0.35	-4.41	-1.04	1.03	-0.21	2.59
Pre-tax income	-8.31	-5.76	6.47	9.98	3.59	-17.1	-108	-20.1	-70.6	-57.1
Income tax	0.67	-5.09	-0.83	-8.99	-1.96	-19.2	-14.7	-4.29	17.9	-10.5
Income from continuing operations	-8.98	-0.67
Net income	-8.98	-0.67	7.3	19	5.55	26.1	-69.8	-10.1	-52.3	-46.6
EBITDA	-3.71	-1.93	12.6	16	8.74	-6.72	-98.9	-13.5	-66.3	-56
EPS, basic	-0.30	-0.02	0.24	0.64	0.18	0.79	-1.88	-0.27	-1.37	-1.21
EPS, diluted	-0.30	-0.02	0.24	0.61	0.18	0.73	-1.88	-0.27	-1.37	-1.21
Shares, basic (weighted)	30.4	30	29.9	29.8	30.2	33.1	37.2	37.5	38.3	38.4
Shares, diluted (weighted)	30.4	30	30.3	31	31.2	35.7	37.2	37.5	38.3	38.4
Dividend per share			0.05	0.10	0.05	0.10	0.10	0.10	0.10	0.10

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	94.7	1.86	2.49	1.7	17.8	19.5	12	11.3	45.4	36.7
Receivables	23.2	35.8	35.9	41.6	50.5	66.2	48.1	54	43.7	44.8
Inventory	45.4	58.1	64.9	73.4	68.4	129	108	91.4	82.3	83
Other current assets	3.48	3.63	5.12	3.79	5.39	11.8	6.3	4.87	5.56	5.46
Total current assets	167	99.4	109	121	142	227	239	300	178	171
Property, plant and equipment	11.1	24.3	23.4	22.9	27	42.8	17.3	16.6	17.6	18.3
Lease right-of-use assets				1.2	5.33	17.6	15.2	15.2	13.8	11.5
Goodwill	0	17.7	18.1	18.1	26.7	91.4	36.3	39.3	3.8
Intangible assets	9.77	23.2	19.4	15.8	19.4	73.7	48.3	41.5	31.5	23.8
Other non-current assets	0.15	0.83	2.03	3.03	6.85	19.6	17.4	16.8	16.6	15.9
Total assets	210	207	213	230	281	632	518	495	294	249
Accounts payable	17.7	19.5	21.5	24.3	21.5	31.5	24.8	20	11.9	15.9
Accrued liabilities			7.45	9.56	13.2	27.5	20.6	24.6	22.3	24.4
Short-term debt	21.9		0.04		4	9.59	11.9	120	1.89
Total current liabilities	40.6	19.8	21.7	24.6	39.6	73	64.6	171	36	40.5
Long-term debt		20.8	22.1	22.7	30.6	132	127
Lease liabilities				0.5	4.41	15.1	12.8	13	11.3	9.27
Other non-current liabilities	0.08	0.18	0.16	0.62	4.63	21.4	15.9	14.2	12.8	10.7
Total liabilities	49.6	44.5	46.9	49.1	76.1	262	226	203	61	52.6
Total debt	21.9	20.8	22.1	22.7	34.6	142	139	120	1.89	0
Paid-in capital	484	485	488	492	514	663	679	691	698	703
Retained earnings	-310	-310	-305	-289	-286	-263	-337	-351	-407	-457
Treasury stock	-12.4	-12.4	-18.1	-22.3	-23.8	-24.4	-32.7	-32.9	-33.1	-33.2
Other comprehensive income	-1.01	0.5	0.48	-0.3	0.5	-5.05	-17.7	-15.4	-24.5	-16.7
Shareholders' equity	161	163	166	181	205	370	292	292	233	196
Total equity	161	163	166	181	205	370	292	292	233	196
Total liabilities and equity	210	207	213	230	281	632	518	495	294	249
Shares outstanding	30	30	29.7	29.8	31.2	37.1	37	38.1	38.4	38.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-8.98	-0.67	7.3	19	5.55	26.1	-69.8	-10.1	-52.3	-46.6
Depreciation and amortization	2.26	2.88	4.42	4.55	4.8	5.99	7.63	7.6	4.03	3.64
Stock-based compensation	0.23	1.18	2.65	2.95	6.79	9.48	11.4	5.29	5.83	5.9
Deferred income tax	-3.67	16.3	2.4	4.25	3.04	2.91	-16.4	-5.21	15.2	-11.3
Change in receivables	2.77	-8.67	-0.77	-6.16	-7.67	-6.46	-8.33	6.08	10.8	-0.97
Change in inventory	5.38	1.36	-7.2	-9.15	11	-34.1	-19.5	13.2	3.74	-1.58
Change in payables	-4.11	-0.14	2.52	1.22	5.01	2.75	1.37	-4.94	-7.97	3.6
Cash from operations	4.81	-8.92	11.4	9.52	29.4	-0.3	14.6	31.9	-7.3	-4.75
Capital expenditures	-2.57	-2.85	-3.37	-4.12	-5.41	-17.4	-8.25	-5.72	-6.74	-5.16
Acquisitions		-79.2	-0.72		-30.5	-161		-5.65	-3.84
Sales and maturities of investments	10.2
Cash from investing	6.77	-82	-4.08	-4.1	-35.6	-178	-7.75	-11.4	165	2.77
Debt repaid		-22.7	-0.04	-0.03
Stock issued		0.18	0.47	1	11.5	80.3	2.72	3.44	0.57
Share buybacks	-5.22	-0.02	-5.69	-4.17	-1.52	-0.65	-8.27	-0.22	-0.19	-0.04
Dividends paid			-1.49	-2.99	-1.52	-3.34	-3.72	-3.75	-3.83	-3.84
Cash from financing	-5.22	-2.06	-6.56	-6.29	22.3	181	-13.9	-20.3	-123	-5.88
Exchange rate effect	-0.02	0.13	-0.13	0.08	0.02	-0.56
Net change in cash	6.34	-92.9	0.63	-0.78	16.1	1.68	-7.4	-0.74	34	-7.16
Free cash flow	2.24	-11.8	8.03	5.41	24	-17.7	6.36	26.2	-14	-9.91
Interest paid	1.24	0.6	0.95	1.09	0.97	2.25	6.59	10.4	1.96	0.02
Income taxes paid	-0.43	0.93	0.42	0.21	0.43	1.98	8.64	-0.76	2.46	0.94

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $3.58 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	36.7%	Gross profit / revenue.
Operating margin	-17.2%	Operating income / revenue.
EBITDA margin	-15.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-15.9%	Pre-tax income / revenue.
Net margin	-12.4%	Net income / revenue.
FCF margin	-0.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	1.7%	Cash from operations / revenue.
Return on equity (ROE)	-15.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-12.3%	Net income / average total assets.
Return on invested capital (ROIC)	-20.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	40.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.9%	Capital expenditures / revenue.
D&A / revenue	1.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-5.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-7.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	2.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-10.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-9.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	1.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	14.9%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-15.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-12.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-0.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-15.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-21.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-2.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	4.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	4.45x	Current assets / current liabilities.
Quick ratio	1.85x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.74x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	22.3%	Total liabilities / total assets.
Working capital	$134.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	8.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	$176.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.99x	Revenue / average total assets.
Fixed asset turnover	13.4x	Revenue / average property, plant and equipment.
Inventory turnover	1.74x	Cost of revenue / average inventory.
Days inventory	210 days	365 x average inventory / cost of revenue.
Receivables turnover	5.86x	Revenue / average receivables.
Days sales outstanding	62 days	365 x average receivables / revenue.
Days payables	41 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	231 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	109.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.82	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$6.59	Revenue / diluted weighted shares.
FCF per share	-$0.01	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.11	Cash from operations / diluted weighted shares.
Book value per share	$5.17	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$4.61	Tangible book value / shares outstanding.
Cash per share	$0.76	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$137.1M	Share price x shares outstanding.
Enterprise value	$108.1M	Market cap + total debt - cash - short-term investments.
P/S	0.54x	Market cap / revenue.
P/B	0.69x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.78x	Market cap / tangible book value, when positive.
P/OCF	31.5x	Market cap / cash from operations, when positive.
EV/Sales	0.43x	Enterprise value / revenue.
FCF yield	-0.3%	Free cash flow / market cap.
Earnings yield	-23.0%	Net income / market cap (the inverse of P/E).
Dividend yield	2.8%	Dividends paid over the period / market cap.
Shareholder yield	3.2%	(Dividends paid + share buybacks) / market cap.

What was Clarus Corp's revenue in fiscal 2025?

Clarus Corp reported revenue of $250.4M for fiscal 2025, 5.2% lower than the year before.

Was Clarus Corp profitable in fiscal 2025?

No. It reported a net loss of $46.6M.

How much free cash flow did Clarus Corp generate in fiscal 2025?

Cash from operations of $4.7M minus capital expenditures of $5.2M left free cash flow of -$9.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Clarus Corp